Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$8.03 - $11.7 $1.61 Million - $2.34 Million
-200,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$9.05 - $12.22 $627,165 - $846,846
69,300 Added 53.02%
200,000 $1.81 Million
Q2 2019

Aug 14, 2019

BUY
$8.75 - $13.03 $1.14 Million - $1.7 Million
130,700 New
130,700 $1.41 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $136M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.